Erasca, Inc. (ERAS)
13.21
-0.16
(-1.20%)
USD |
NASDAQ |
Jun 11, 10:54
Erasca EPS Diluted (Quarterly) : -0.6028 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.6028 |
| December 31, 2025 | -0.1025 |
| September 30, 2025 | -0.1079 |
| June 30, 2025 | -0.1196 |
| March 31, 2025 | -0.1093 |
| December 31, 2024 | -0.114 |
| September 30, 2024 | -0.1105 |
| June 30, 2024 | -0.2902 |
| March 31, 2024 | -0.2316 |
| December 31, 2023 | -0.197 |
| September 30, 2023 | -0.2018 |
| June 30, 2023 | -0.2118 |
| March 31, 2023 | -0.2221 |
| Date | Value |
|---|---|
| December 31, 2022 | -1.060 |
| September 30, 2022 | -0.2938 |
| June 30, 2022 | -0.2962 |
| March 31, 2022 | -0.3051 |
| December 31, 2021 | -0.2564 |
| September 30, 2021 | -0.38 |
| June 30, 2021 | -0.2328 |
| March 31, 2021 | -0.1515 |
| December 31, 2020 | -0.5204 |
| September 30, 2020 | -0.0875 |
| June 30, 2020 | -0.0462 |
| March 31, 2020 | -0.1989 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -2.291 |
| Tango Therapeutics, Inc. | -0.317 |
| Kymera Therapeutics, Inc. | -0.7098 |
| Bridgebio Oncology Therapeutics, Inc. | -526.11 |
| ImmunityBio, Inc. | -0.6162 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -183.44M |
| Total Expenses (Quarterly) | 183.44M |
| Enterprise Value | 3.958B |
| Earnings Yield | -7.06% |
| Normalized Earnings Yield | -4.272 |